Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be an internal version update with no visible changes to the page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe funding-status notice about potential delays due to government funding has been removed. The core study information (title, conditions, eligibility, outcomes) remains unchanged.SummaryDifference0.3%

- Check35 days agoChange DetectedPost-results update timestamps were added to the study page, including Results First Submitted and Results First Posted dates in 2025. The page now reflects the updated results timeline for NCT03035331.SummaryDifference0.3%

- Check70 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

- Check77 days agoChange Detected- The page now indicates Revision: v3.1.0. - The term 'Diffuse large b-cell lymphoma' has been removed. - Revision tag changed from v3.0.2 to v3.1.0 implies an update to core content. If the medical term was part of product or article context, its removal may affect related references.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdated version from v3.0.1 to v3.0.2; removed the Back to Top link. No other substantive changes.SummaryDifference0.1%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.